Tradestie Institutional Equity Comparison Engine
ICCC vs INTG โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
ICCC Overall Edge
ICCC Captures Institutional Edge (2โ1 Pillars ยท 5โ3 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Immucell Corp (ICCC) driven by superior Valuation, Momentum & Technical while INTG counters with relative strength in Growth & Margin. Fundamentally, ICCC trades at N/M Forward P/E with 15.2% operating margin (+11.5% YoY revenue) versus INTG at N/M Forward P/E and 16.1% operating margin (+13.3% YoY). In options structure, ICCC sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against INTG sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
ICCC
ICCC N/M vs INTG N/M Fwd P/E
Growth & Margin Winner
INTG
Op Margin 15.2% vs 16.1% ยท YoY +11.5% vs +13.3%
Momentum & Technical Winner
ICCC
1Y +88.8% vs +11.4% ยท 52W Pos 91% vs 61%
Options & Structure Winner
Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
ICCC
NASDAQ
Immucell Corp
In Vitro & In Vivo Diagnostic Substances
$11.42
+6.23% 1D
Market Cap
$97.7M
1M Return
+6.23%
1Y Return
+88.76%
Forward P/E
N/M
Unified AI Score
43.8 / 100
HOLD
Tech 15.0
Fund 48.0
Flow 50.0
Mom 50.0
INTG
NASDAQ
Intergroup Corporation (The)
Operators Of Apartment Buildings
$41.48
-0.65% 1D
Market Cap
$89.7M
1M Return
+28.1%
1Y Return
+11.36%
Forward P/E
N/M
Unified AI Score
32.5 / 100
SELL
Tech 15.0
Fund 33.0
Flow 50.0
Mom 30.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
ICCC +88.76%
INTG +11.36%
Spread: +66.8 pp (ICCC Lead)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | ICCC Revenue | INTG Revenue | ICCC Op. Margin | INTG Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2019 | $10M | $70M | -7.0% | 20.3% | INTG |
| FY2020 | $20M | $60M | -9.0% | 8.4% | INTG |
| FY2021 | $20M | $30M | 1.3% | -17.0% | ICCC |
| FY2022 | $20M | $50M | -12.4% | 7.8% | INTG |
| FY2023 | $20M | $60M | -32.9% | 7.5% | INTG |
| FY2024 | $30M | $60M | -6.2% | 2.5% | INTG |
| FY2025 | $30M | $60M | 6.0% | 11.9% | INTG |
| FY2026 | N/A | $70M | N/A | 16.0% | INTG |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | ICCC | INTG | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $97.7M | $89.7M | Larger Scale | Tie |
| Trailing P/E Ratio Valuation | 56.6x | 58.8x | Lower Multiple | ICCC |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | +11.5% | +13.3% | Higher Growth | INTG |
| Operating Margin (TTM) Profitability | 15.2% | 16.1% | Higher Margin | INTG |
| Net Profit Margin Profitability | 2.6% | 2.2% | Higher Margin | ICCC |
| Return on Equity (ROE) Capital Efficiency | 2.6% | 0.0% | Higher ROE | ICCC |
| 52-Week Range Position Momentum | 91% ($5โ$12) | 61% ($25โ$52) | Stronger Trend | ICCC |
| Beta / 30D Volatility Risk Regime | 0.24ฮฒ ยท 46% Vol | -0.14ฮฒ ยท 42% Vol | Lower Realized Risk | INTG |
| Unified Institutional Score Composite Signal | 43.8 / 100 (HOLD) | 32.5 / 100 (SELL) | Higher Composite | ICCC |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full ICCC vs INTG Buy Guide
ICCC
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
INTG
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither ICCC nor INTG registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.